Bioreactor

News

Pluristem Retains KKS as Its CRO for Upcoming Limb Ischemia Clinical Trial

Published December 1, 2008, 1:17 am, Centre Daily Times

Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company signed an agreement with KKS, retaining them as the Contract Research Organization (CRO) for its upcoming Critical Limb ...

Discover News | Full Story


Pluristem Retains KKS as Its CRO for Upcoming Limb Ischemia Clinical Trial

Published December 1, 2008, 1:00 am, Business Wire via Yahoo! Finance

NEW YORK----Pluristem Therapeutics Inc. , a bio-therapeutics company dedicated to the commercialization of non-personalized cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company signed an agreement with KKS, retaining them as the Contract Research Organization for its upcoming Critical Limb Ischemia multi center clinical trial ...

Discover News | Full Story


Water facility nabs design award

Published November 29, 2008, 10:18 pm, The News-Press

The Bonita Springs Utilities East Water Reclamation Facility won a National Design-Build Award from the Design-Build Institute of America recently.

Discover News | Full Story


Electric Fields Clean Up Bioreactors

Published November 29, 2008, 4:12 am, Medical News Today

Researchers from EKB Technology - a spinout joint venture between the University of Oxford and C-Tech Innovation - have announced positive results from an elegant method of improving mammalian cell bioreactors.

Discover News | Full Story


ABS-CBN News Online Beta

Published November 26, 2008, 12:09 pm, ABS-CBNNEWS.com

PARIS – The pioneering transplant of a windpipe stripped of its cells and seeded with recipient stem cells has given a 30-year old Colombian woman a new lease on life, according to a study released Wednesday.

Discover News | Full Story


Local News

Published November 25, 2008, 8:05 am, The Community Press

Brighton – The solution to ending above-average levels of ammonia and ammonium nitrogen concentrations being discharged from the lagoon at Brighton's wastewater plant and eventually exiting into Lake Ontario will cost the municipality $6.4 million.

Discover News | Full Story


My Pharmiweb.com

Published November 25, 2008, 6:18 am, PharmiWeb

Resources | Features | Merck Serono invests €300 million i... It takes courage to invest €300 million in a production site during a time of financial turmoil”,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.

Discover News | Full Story


DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter

Published November 25, 2008, 5:36 am, PR Newswire via Yahoo! Finance

DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. , today announced that Hungary-based Gedeon Richter Plc. signed a commercial license agreement allowing Gedeon Richter to develop and produce certain biopharmaceuticals on the PER.C6® platform.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a